(February 20 06:41) Forbes.com
Pfizer CEO Albert Bourla said Friday there wasn’t clear evidence yet on whether it would be safe to forgo a second dose of its coronavirus vaccine or delay administering it, a day after a study showed robust immunity after just one shot.
You can find the original article
here